Sector ratings Charles River Laboratories International, Inc. Berne S.E.

Stocks

End-of-day quote Berne S.E. 2026-09-29			5-day change	1st Jan Change
242.51 ^CHF	-0.45%		+2.94%	-

Sep. 29	PMGC Unit Working With Charles River Laboratories for Muscle Health Probiotic Testing	MT
Sep. 28	Jefferies Adjusts PT on Charles River Laboratories International to $340 From $305, Maintains Buy Rating	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
LONZA GROUP AG	49.06B		AAA
IQVIA HOLDINGS INC.	44.6B		AAA
REVOLUTION MEDICINES, INC.	43.24B	-	B	-	-
BEONE MEDICINES AG	41.73B		-
CELLTRION, INC.	29.93B		A
MEDPACE HOLDINGS, INC.	17.19B		BBB
TEMPUS AI, INC.	15.35B		A		-
EUROFINS SCIENTIFIC SE	15.54B		AA
ASCENDIS PHARMA A/S	15.11B	-	-	-	-
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	14.06B		AA
ICON PUBLIC LIMITED COMPANY	13.55B		AAA
GENSCRIPT BIOTECH CORPORATION	12.21B		AA		-
BIO-TECHNE CORPORATION	11.37B		AA
PHARMARON BEIJING CO., LTD.	10.86B		AA
KYMERA THERAPEUTICS, INC.	9.31B	-	BBB	-	-
PROTAGONIST THERAPEUTICS, INC.	9.22B		BB		-
QIAGEN N.V.	9.31B		AAA
ABIVAX	8.31B	-	BBB	-	-
PRAXIS PRECISION MEDICINES, INC.	7.98B	-	B	-	-
Average	19.89B		AA
Weighted average by Cap.			AA